Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trimas (TRS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Trimas (TRS) over the last 16 years, with Q3 2025 value amounting to $50000.0.

  • Trimas' Gains from Investment Securities fell 1666.67% to $50000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 2134.15%. This contributed to the annual value of $1.8 million for FY2024, which is 3481.48% down from last year.
  • Per Trimas' latest filing, its Gains from Investment Securities stood at $50000.0 for Q3 2025, which was down 1666.67% from $40000.0 recorded in Q2 2025.
  • Over the past 5 years, Trimas' Gains from Investment Securities peaked at $2.8 million during Q2 2021, and registered a low of $20000.0 during Q4 2023.
  • Moreover, its 5-year median value for Gains from Investment Securities was $280000.0 (2023), whereas its average is $818823.5.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 7862.6% in 2023, then surged by 60000.0% in 2024.
  • Quarter analysis of 5 years shows Trimas' Gains from Investment Securities stood at $540000.0 in 2021, then crashed by 81.48% to $100000.0 in 2022, then crashed by 80.0% to $20000.0 in 2023, then skyrocketed by 600.0% to $140000.0 in 2024, then plummeted by 64.29% to $50000.0 in 2025.
  • Its Gains from Investment Securities was $50000.0 in Q3 2025, compared to $40000.0 in Q2 2025 and $1.8 million in Q1 2025.